Use of the feminizing hormone therapy medroxyprogesterone acetate (MPA) results in minimal side effects, unchanged oestradiol levels and a decline in testosterone in a cohort of transwomen, a study has found.
Markedly different blood glucose responses and postexercise profiles are associated with fasting morning resistance exercise (RE) compared with afternoon RE in individuals with type 1 diabetes (T1D), a recent study has shown.
Radiofrequency ablation and neuromodulation modalities for knee osteoarthritis (OA) potentially improve pain, functionality and disease-specific quality of life for up to 3–12 months with minimal localized complications, according to the results of a systematic review.
Quality of life (QoL) in breast cancer patients worsens 2 years following diagnosis with different courses by treatment received, a study has found. Specifically, endocrine therapy exerts a major detrimental impact on QoL as opposed to chemotherapy having a transient negative effect in postmenopausal patients.
Acute systemic illnesses or thrombotic events may trigger acute ischaemic stroke (AIS) in children with cardiac disease, a recent study has shown. Many of these events occur beyond the usual periprocedural window.
Digoxin remains widely prescribed despite a decreasing trend in its use, according to a US study. Moreover, the rate of hospitalizations for digoxin toxicity and adverse outcomes associated with these hospitalizations have both decreased.
Low total cholesterol levels appear to carry increased major adverse cardiovascular events (MACE) hazard in older men without ischaemic heart disease (IHD) and not receiving statin therapy but not to those on statins, according to data from the CHAMP (Concord Health and Ageing in Men Project) cohort.